查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1939560

全球膽道支架系統市場（按支架類型、植入方式、應用、最終用戶和分銷管道分類）預測（2026-2032年）

Covered Biliary Stent System Market by Stent Type, Deployment Procedure, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年，覆膜膽道支架系統市值為3.693億美元，預計2026年將成長至3.9206億美元，年複合成長率為5.81%，到2032年將達到5.485億美元。

關鍵市場統計數據
基準年 2025 3.693億美元
預計年份：2026年 3.9206億美元
預測年份 2032 5.485億美元
複合年成長率 (%) 5.81%

本文簡要概述了臨床創新、醫療設備性能和醫療服務動態之間複雜的相互作用如何影響膽道支架系統。

膽道支架系統的現狀正處於臨床實踐、醫療設備工程和醫療系統物流的關鍵交會點。材料科學和內視鏡技術的進步重塑了介入團隊治療膽道阻塞的方式，而不斷完善的臨床指南和日益精細化的手術操作也拓展了支架置入的適應症範圍。同時，供應商網路、醫院採購通訊協定和通路也變得日益複雜，這要求製造商和醫療服務提供者在臨床療效和營運效率之間取得平衡。

技術成熟度、流程改善和商業性差異化將如何重新定義膽道支架系統的臨床價值和競爭優勢

膽道支架領域近期發生的變革性變化，是技術成熟、手術流程標準化和市場主導共同作用的結果。在技​​術方面，塗層、聚合物科學和支架結構方面的創新降低了支架移位和阻塞的風險，同時提高了透過更小尺寸內視鏡進行輸送的便利性。影像和內視鏡技術的同步進步提高了手術精度，實現了支架在目標部位的精準放置，並擴大了可治療的解剖範圍。這些技術進步也伴隨著對以患者為中心的終點指標的日益重視，例如提高患者的生活品質和減少再次手術。

預計到2025年，關稅主導的供應鏈重組和籌資策略重組將對製造業、採購和競爭地位產生影響。

預計到2025年，美國將對關稅進行調整，這將對依賴全球供應鏈的製造商、經銷商和醫療保健系統產生實際影響。關稅將改變進口零件和成品的到岸成本，迫使製造商重新評估其定價、籌資策略和區域製造地。為此，一些供應商可能會加快關鍵零件的本地化生產或協商新的供應協議以保障利潤率，而另一些供應商則可能重新設計包裝或物流以減輕關稅負擔。

全面的細分分析揭示了設備類型、臨床適應症、臨床環境、通路和手術流程如何驅動採用趨勢。

關鍵細分分析揭示了器械類型、臨床應用、最終用戶、分銷管道和實施流程等方面的不同趨勢，這些因素共同塑造了器械的採納和創新路徑。依支架類型分析，可分為生物可吸收支架、藥物釋放型支架、金屬支架和塑膠支架，其中金屬支架可進一步細分為覆膜金屬支架和裸金屬支架。通暢率、移位風險和可回收性等效能權衡會影響臨床偏好和器械選擇標準。在適應症方面，良性和惡性狹窄的治療模式有所不同。良性病例包括慢性胰臟炎和膽結石，而惡性病例包括膽管癌和胰臟癌。這些臨床情況決定了器械的預期壽命、併發症接受度和跨學科護理協調。

區域評估支付模式、監管多樣性、手術普及程度和本地生產對市場進入和商業化策略的影響

區域趨勢對膽道支架領域的臨床通訊協定、監管路徑和商業模式有顯著影響。在美洲，醫院系統的整合以及對綜合支付模式的重視，正在推動能夠顯著降低再入院率和再次手術率的解決方案。該地區的臨床醫生和採購團隊通常要求提供強力的上市後證據和便捷的服務支持，從而促使對培訓和生命週期項目進行投資。同時，在歐洲、中東和非洲，法規環境不均衡，支付方結構也各不相同，區域報銷規則和基礎設施能力決定支架技術的選擇和應用速度。

設備創新、臨床證據產生和綜合服務模式如何塑造競爭格​​局和長期商業性夥伴關係

膽道支架系統的競爭主要取決於臨床差異化、供應鏈實力以及提供全面客戶支援的能力。投資於器材創新、可靠的臨床證據和綜合培訓計畫的主要企業，在產能龐大的生產設施和專業網路中佔據有利地位。同時，靈活的區域性企業則利用製造地接近性和成本優勢，瞄準價格敏感型市場，並根據臨床醫生的回饋快速改進產品設計。

在市場壓力日益增大的情況下，製造商和供應商如何採取切實可行的策略來推動產品應用、建立支付方信任並加強供應鏈？

為了應對短期挑戰並掌握不斷變化的機遇，產業領導者應優先考慮臨床差異化和營運韌性這兩大關鍵要素。首先，投資真實世界證據計畫和多中心註冊研究，以展示相關臨床亞群的療效。這種方法將增強臨床可信度，並為醫保報銷談判提供支援。其次，透過儘早與關鍵意見領袖 (KOL) 接洽，並整合回饋機制以支援迭代式設計改進，從而使產品開發與流程順暢銜接。第三，透過區域籌資策略和緊急時應對計畫提高供應鏈柔軟性，以降低關稅和物流波動帶來的風險。

一種透明、以證據主導的研究途徑，整合了臨床醫生訪談、設備技術分析和監管法規梳理，以支持策略決策。

本研究系統性地整合了一級資訊來源和二級資訊來源，力求平衡臨床醫師的見解、商業資訊和技術設備評估。一級資訊來源包括對介入內視鏡醫師、採購人員和設備技術人員的訪談，從而獲得關於臨床重點、設備操作注意事項和醫院採購行為的第一手觀點。二級資訊來源包括同行評審的臨床文獻、監管申報文件、產品規格和行業出版物，用於檢驗技術聲明並梳理監管路徑。整合過程優先考慮高品質證據和對聲明的交叉檢驗，以得出可靠的結論。

本文簡要總結了臨床、營運和商業性因素，這些因素將決定哪些企業能夠將創新轉化為持續應用並改善患者預後。

總之，膽道支架系統產業的特點是技術創新迅速、臨床差異化程度高以及商業性化程度不斷提高。新材料、塗層技術和手術流程的改進正在融合，以拓展治療可能性並改善患者預後，同時也需要加強對培訓、實證醫學和供應鏈適應性的投入。關稅趨勢和區域市場結構進一步增加了策略規劃的複雜性，凸顯了靈活採購和客製化打入市場策略的必要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依支架類型分類的覆膜膽道支架系統市場

  • 生物可吸收支架
  • 藥物釋放型支架
  • 金屬支架
    • 覆膜金屬支架
    • 未塗層金屬支架
  • 塑膠支架

9. 依安裝程序分類的覆膜膽道支架系統市場

  • 內視鏡逆行性胰造影
  • 經皮肝內造影

10. 覆膜膽道支架系統市場（依應用分類）

  • 良性狹窄
    • 慢性胰臟炎
    • 膽結石
  • 惡性狹窄
    • 膽管癌
    • 胰臟癌

11. 依最終用戶分類的覆膜膽道支架系統市場

  • 門診手術中心
  • 醫院
  • 專科診所

12. 按分銷管道分類的覆膜膽道支架系統市場

  • 直銷
  • 電子商務
  • 醫院頻道
  • 零售藥房

13. 各地區有蓋膽道支架系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

14. 覆膜膽道支架系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國有蓋膽道支架系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國覆膜膽道支架系統市場

17. 中國覆膜膽道支架系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • B. Braun Melsungen AG
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical LLC
  • ELLA-CS, sro
  • Endo-Flex GmbH
  • Fujifilm Holdings Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Taewoong Medical Co., Ltd.
  • WL Gore & Associates, Inc.
Product Code: MRR-9A6A6F297857

The Covered Biliary Stent System Market was valued at USD 369.30 million in 2025 and is projected to grow to USD 392.06 million in 2026, with a CAGR of 5.81%, reaching USD 548.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 369.30 million
Estimated Year [2026] USD 392.06 million
Forecast Year [2032] USD 548.50 million
CAGR (%) 5.81%

A concise orientation to the complex convergence of clinical innovation, device performance, and healthcare delivery dynamics influencing biliary stent systems

The biliary stent systems landscape occupies a critical intersection of clinical practice, device engineering, and health system logistics. Advances in material science and endoscopic techniques have reshaped how interventional teams approach biliary obstruction management, while evolving clinical guidelines and growing procedural expertise have broadened indications for stent deployment. At the same time, supplier networks, hospital purchasing protocols, and distribution channels have become more complex, compelling manufacturers and providers to synchronize clinical performance with operational efficiency.

Consequently, stakeholders must balance clinical outcomes with device lifecycle considerations, regulatory compliance, and procurement realities. Clinicians prioritize stent patency and complication reduction, whereas hospital administrators focus on total cost of care and the ease of integration into existing procedural workflows. As technologies such as bioabsorbable scaffolds and drug-eluting coatings mature, they introduce new clinical value propositions but also require updated pathways for training, inventory management, and reimbursement coding. Therefore, a clear understanding of device attributes, procedural contexts, and end-user environments is essential to navigate adoption hurdles and to identify the most promising opportunities for innovation and commercialization.

How technological maturation, procedural refinement, and commercial differentiation are redefining clinical value and competitive advantage across biliary stent systems

Recent transformative shifts in the biliary stent field reflect a combination of technological maturation, procedural standardization, and market-driven imperatives. On the technology front, innovations in coatings, polymer science, and stent architecture have reduced migration and occlusion risks while improving deliverability through narrower endoscopes. Parallel improvements in imaging and endoscopic techniques have increased procedural precision, enabling targeted placement and extending the range of treatable anatomies. These technical gains have been accompanied by a stronger emphasis on patient-centric endpoints such as quality of life and reduced repeat interventions.

Operationally, stakeholders have adapted to changing procurement expectations by emphasizing lifecycle support, training programs, and bundled service models. Payers and health systems increasingly request evidence of long-term clinical benefit and real-world performance, motivating manufacturers to invest in post-market surveillance and registry data. At the same time, competitive dynamics have pushed suppliers to differentiate through integrated solutions that combine device performance with digital tools, procedural training, and streamlined supply chain arrangements. Moving forward, the market will likely favor players who can couple demonstrable clinical advantages with clear operational value and scalable support models.

Projected tariff-driven supply chain realignments and procurement recalibrations that will affect manufacturing, sourcing, and competitive positioning through 2025

Anticipated tariff adjustments in the United States through 2025 create tangible implications for manufacturers, distributors, and health systems that rely on global supply chains. Tariffs can alter landed costs for imported components and finished devices, prompting manufacturers to reassess pricing, sourcing strategies, and regional manufacturing footprints. In response, some suppliers may accelerate localization of critical components or negotiate new supplier contracts to shield margins, while others could redesign packaging and logistics to reduce tariff exposure.

These tariff-induced cost pressures also cascade into procurement behavior within hospitals and ambulatory settings. Buyers may place greater emphasis on total acquisition cost and supplier flexibility, and they may welcome value-based contracting that aligns payment with device performance over time. In addition, distributors and e-commerce channels might evolve their inventory strategies to manage currency volatility and tariff pass-through. Ultimately, tariffs will not only influence pricing but also strategic decisions around supply chain resilience, regional manufacturing partnerships, and the relative attractiveness of domestic versus imported offerings, thereby reshaping competitive positioning across the ecosystem.

Comprehensive segmentation perspectives revealing how device type, clinical indication, care setting, distribution pathway, and procedural route determine adoption dynamics

Key segmentation insights reveal differentiated dynamics across device types, clinical applications, end users, distribution channels, and deployment procedures, each shaping adoption and innovation pathways. When analyzed by stent type, the landscape includes bioabsorbable stent, drug-eluting stent, metal stent, and plastic stent, with the metal stent category further distinguishing between covered metal stent and uncovered metal stent; performance trade-offs such as patency duration, migration risk, and retrievability influence clinical preference and device selection criteria. Regarding application, practice patterns differ between benign stricture and malignant stricture, where benign cases include chronic pancreatitis and gallstones and malignant cases include cholangiocarcinoma and pancreatic cancer; these clinical contexts dictate expected device lifespan, complication tolerance, and multidisciplinary care coordination.

In terms of end users, settings encompass ambulatory surgical center, hospital, and specialty clinic, and each presents distinct procurement cycles, inventory constraints, and procedural volumes that affect purchasing decisions. Distribution channels range from direct sales and e-commerce to hospital channel and retail pharmacy, with channel selection influenced by regulatory pathways, reimbursement models, and service expectations. Finally, deployment procedures such as endoscopic retrograde cholangiopancreatography and percutaneous transhepatic cholangiography require different device characteristics and operator competencies, thereby influencing training needs and product design. Taken together, these segmentation layers create a mosaic of clinical and commercial conditions that suppliers must navigate to align product attributes with user requirements and market access strategies.

A regional assessment of how payment models, regulatory diversity, procedural adoption, and local manufacturing shape market access and commercialization strategies

Regional dynamics exert a strong influence on clinical protocols, regulatory pathways, and commercial models across the biliary stent domain. In the Americas, consolidation among hospital systems and an emphasis on bundled payment models encourage solutions that deliver measurable reductions in readmissions and repeat procedures. Clinicians and procurement teams in this region often demand strong post-market evidence and convenient service support, which drives investment in training and lifecycle programs. Conversely, Europe, Middle East & Africa displays heterogeneous regulatory environments and variable payer structures, where local reimbursement rules and infrastructure capacity shape the selection of stent technologies and the pace of adoption.

In Asia-Pacific, rapid adoption of minimally invasive techniques, growing procedural volumes, and strong local manufacturing ecosystems create fertile ground for both established international players and domestic innovators. Across all regions, cross-border supply chain considerations, local production incentives, and differences in procedural guidelines contribute to distinct commercialization strategies. Manufacturers and distributors must therefore tailor market entry approaches, regulatory engagement, and post-sale support to the region-specific needs and constraints in order to secure clinical acceptance and sustainable commercial outcomes.

How device innovation, clinical evidence generation, and integrated service models are shaping the competitive landscape and long-term commercial partnerships

Competitive dynamics in biliary stent systems are driven by the interplay of clinical differentiation, supply chain strength, and the ability to provide comprehensive customer support. Leading firms that invest in device innovation, robust clinical evidence, and integrated training programs secure preferential positions with high-volume centers and specialty networks. At the same time, nimble regional players leverage manufacturing proximity and cost advantages to serve price-sensitive markets and to iterate designs quickly in response to clinician feedback.

Strategic partnerships between device manufacturers, distributors, and healthcare providers are increasingly common, enabling bundled service models and registry collaborations that demonstrate long-term value. Moreover, companies that standardize product interfaces across procedural platforms and offer strong technical support reduce clinician friction and accelerate adoption. From a go-to-market perspective, success often correlates with the ability to synchronize clinical marketing, payer engagement, and supply chain reliability. Consequently, organizations that balance R&D commitments with practical investments in training, evidence generation, and post-market follow-up are positioned to capture durable clinical partnerships and to expand their commercial footprint.

Practical strategic imperatives for manufacturers and suppliers to accelerate adoption, build payer confidence, and fortify supply chain resilience amid evolving market pressures

Industry leaders should prioritize a dual agenda of clinical differentiation and operational resilience to navigate near-term challenges and to capitalize on evolving opportunities. First, invest in real-world evidence programs and multi-center registries that demonstrate outcomes across relevant clinical subsets; this approach will strengthen clinical credibility and support reimbursement discussions. Second, align product development with procedural workflows by engaging key opinion leaders early and by integrating feedback loops that inform iterative design improvements. Third, enhance supply chain flexibility through regional sourcing strategies and contingency planning to mitigate tariff and logistics volatility.

Additionally, firms should expand post-sale services, including modular training packages and remote support capabilities, to reduce clinician onboarding time and to increase procedural consistency. Commercial teams must refine value propositions for different end-user segments by articulating total cost of care benefits rather than unit price alone. Finally, pursue selective partnerships with health systems and distributors to pilot bundled contracting or outcome-linked agreements that de-risk payer adoption and accelerate scale. Taken together, these steps will help companies create durable differentiation while improving adoption velocity and payer alignment.

A transparent, evidence-driven research approach integrating clinician interviews, technical device analyses, and regulatory mapping to support strategic decision-making

This research synthesizes primary and secondary sources through a structured approach that balances clinician insight, commercial intelligence, and technical device evaluation. Primary inputs included interviews with interventional endoscopists, procurement leaders, and device engineers, which provided firsthand perspectives on clinical priorities, device handling considerations, and hospital purchasing behaviors. Secondary inputs encompassed peer-reviewed clinical literature, regulatory filings, product specifications, and industry publications to validate technical claims and to map regulatory pathways. The synthesis prioritized high-quality evidence and cross-validation of assertions to ensure robust conclusions.

Analytical methods combined qualitative thematic analysis with comparative device profiling to identify performance differentiators and operational implications. Regional regulatory and reimbursement frameworks were mapped to align commercialization recommendations with local constraints. Where appropriate, sensitivity checks were applied to reconcile divergent stakeholder views. Throughout the process, emphasis was placed on transparent documentation of sources and analytic assumptions so that decision-makers can trace conclusions back to their evidentiary basis and adapt insights to their specific strategic questions.

A concise synthesis of clinical, operational, and commercial drivers that will determine which players convert innovation into sustained adoption and improved patient outcomes

In conclusion, the biliary stent systems arena is characterized by rapid technical innovation, nuanced clinical differentiation, and intensifying commercial sophistication. New materials and coatings, combined with procedural refinements, are expanding therapeutic possibilities and improving patient outcomes, yet they also require coordinated investments in training, evidence generation, and supply chain adaptability. Tariff dynamics and regional market structures further complicate strategic planning, underscoring the need for flexible sourcing and tailored go-to-market strategies.

Ultimately, stakeholders that align device attributes with specific clinical use cases, invest in post-market evidence, and cultivate operational excellence will be best positioned to lead. Collaboration among manufacturers, clinicians, payers, and distributors will remain essential to translate product innovation into scalable clinical benefit. By focusing on demonstrable patient outcomes and by designing solutions that integrate seamlessly into clinical workflows, organizations can convert technical advances into enduring commercial success and improved standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Covered Biliary Stent System Market, by Stent Type

  • 8.1. Bioabsorbable Stent
  • 8.2. Drug-Eluting Stent
  • 8.3. Metal Stent
    • 8.3.1. Covered Metal Stent
    • 8.3.2. Uncovered Metal Stent
  • 8.4. Plastic Stent

9. Covered Biliary Stent System Market, by Deployment Procedure

  • 9.1. Endoscopic Retrograde Cholangiopancreatography
  • 9.2. Percutaneous Transhepatic Cholangiography

10. Covered Biliary Stent System Market, by Application

  • 10.1. Benign Stricture
    • 10.1.1. Chronic Pancreatitis
    • 10.1.2. Gallstones
  • 10.2. Malignant Stricture
    • 10.2.1. Cholangiocarcinoma
    • 10.2.2. Pancreatic Cancer

11. Covered Biliary Stent System Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Hospital
  • 11.3. Specialty Clinic

12. Covered Biliary Stent System Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. E-Commerce
  • 12.3. Hospital Channel
  • 12.4. Retail Pharmacy

13. Covered Biliary Stent System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Covered Biliary Stent System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Covered Biliary Stent System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Covered Biliary Stent System Market

17. China Covered Biliary Stent System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Boston Scientific Corporation
  • 18.7. CONMED Corporation
  • 18.8. Cook Medical LLC
  • 18.9. ELLA-CS, s.r.o.
  • 18.10. Endo-Flex GmbH
  • 18.11. Fujifilm Holdings Corporation
  • 18.12. Medtronic plc
  • 18.13. Merit Medical Systems, Inc.
  • 18.14. Micro-Tech (Nanjing) Co., Ltd.
  • 18.15. Olympus Corporation
  • 18.16. Taewoong Medical Co., Ltd.
  • 18.17. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL COVERED BILIARY STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BIOABSORBABLE STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DRUG-ELUTING STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY UNCOVERED METAL STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PLASTIC STENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHRONIC PANCREATITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GALLSTONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY CHOLANGIOCARCINOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY HOSPITAL CHANNEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 159. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 160. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 162. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GCC COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 186. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 187. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 189. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 195. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 196. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 198. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL COVERED BILIARY STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY STENT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY METAL STENT, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DEPLOYMENT PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY MALIGNANT STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA COVERED BILIARY STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)